Blog
Hardman & Co: Q&A on Shield Therapeutics (STX): Upside potential is enormous
Hardman & Co: Q&A on Shield Therapeutics (STX): Upside potential is enormous
DGAP-News: Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million
DGAP-News: Heidelberg Pharma AG Launches Rights Issue of up to EUR 80 Million
Lenta IPJSC: Lenta Announces Results of EGM
Lenta IPJSC: Lenta Announces Results of EGM
DGAP-Adhoc: ZEAL Network SE: Subsidiary myLotto24 obtains final annulment of VAT assessment
DGAP-Adhoc: ZEAL Network SE: Subsidiary myLotto24 obtains final annulment of VAT assessment
DGAP-News: Nagarro SE posts 65.0% YoY revenue growth in Q2
DGAP-News: Nagarro SE posts 65.0% YoY revenue growth in Q2
Nordea Bank Abp: Transaction in Own Shares
Nordea Bank Abp: Transaction in Own Shares
DGAP-News: W&W Group: Strong operational performance in first half of 2022
DGAP-News: W&W Group: Strong operational performance in first half of 2022
DGAP-News: KATEK SE: KATEK raises sales forecast to over EUR 615 million after strongest half-year in company history
DGAP-News: KATEK SE: KATEK raises sales forecast to over EUR 615 million after strongest half-year in company history
DGAP-News: Photon Energy Group Generates Record July Revenues
DGAP-News: Photon Energy Group Generates Record July Revenues
DGAP-News: TTL Beteiligungs- und Grundbesitz-AG: TTL publishes 2022 half-year figures
DGAP-News: TTL Beteiligungs- und Grundbesitz-AG: TTL publishes 2022 half-year figures
DGAP-News: elumeo SE stops decline in sales and closes first half of 2022 with positive result
DGAP-News: elumeo SE stops decline in sales and closes first half of 2022 with positive result
Royal KPN N.V. Press Release: KPN completes € 300m share buyback
Royal KPN N.V. Press Release: KPN completes € 300m share buyback
Unaudited NAV for July 2022
Unaudited NAV for July 2022
SWEF: Transaction in Own Shares
SWEF: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
Cairn Homes Plc: Transaction in Own Shares
DGAP-News: ADM Energy PLC: 17th Cargo Lifting at Aje Field
DGAP-News: ADM Energy PLC: 17th Cargo Lifting at Aje Field
DGAP-News: EQS Group continues on growth trajectory in first half of 2022
DGAP-News: EQS Group continues on growth trajectory in first half of 2022
DGAP-News: Energiekontor AG remains on growth course in H1 FY2022 in a challenging market environment
DGAP-News: Energiekontor AG remains on growth course in H1 FY2022 in a challenging market environment
DGAP-News: MBB SE increases revenues by 16% in the first half with a growing EBITDA margin of 10%
DGAP-News: MBB SE increases revenues by 16% in the first half with a growing EBITDA margin of 10%
DGAP-News: Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR -0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022
DGAP-News: Q2/2022: Sales of EUR 2.7 million and EBITDA of EUR -0.2 million below expectations in persistently challenging macroeconomic environment; growth expected for second half of 2022
DGAP-News: FRIEDRICH VORWERK increases order intake by 142% in the first half of the year, achieves revenues of €143 million with an adjusted EBIT margin of 10% and adjusts profitability forecast
DGAP-News: FRIEDRICH VORWERK increases order intake by 142% in the first half of the year, achieves revenues of €143 million with an adjusted EBIT margin of 10% and adjusts profitability forecast
DGAP-News: SMT Scharf AG reports successful business performance in the first half of 2022
DGAP-News: SMT Scharf AG reports successful business performance in the first half of 2022
DGAP-News: Strong first half-year for GESCO in 2022
DGAP-News: Strong first half-year for GESCO in 2022
DGAP-News: Aumann AG: Aumann confirms growth path with €166 million order intake in the first half of 2022 and a record order backlog of €249 million
DGAP-News: Aumann AG: Aumann confirms growth path with €166 million order intake in the first half of 2022 and a record order backlog of €249 million
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease
Relief Therapeutics and Acer Therapeutics Announce that the European Commission Has Granted Orphan Drug Designation for ACER-001 in Maple Syrup Urine Disease


